FMS vs. SOLV: Fresenius Medical Care vs. Solventum Stock Comparison

Company Profile

Fresenius Medical Care (FMS) and Solventum (SOLV) both fall under the Health Care Equipment & Services industry group, but FMS is classified in Health Care Providers & Services while SOLV is classified in Health Care Equipment & Supplies.

Fresenius Medical Care (FMS) carries decades of public-market history since September 17, 1996, while Solventum (SOLV) listed on March 26, 2024 — long-window comparisons have far more historical data on the FMS side.

Solventum (SOLV) trades as ordinary local shares, while Fresenius Medical Care (FMS) trades as an ADR — compare with FX exposure, depositary-program fees, and dividend-withholding-tax differences in mind.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Both Fresenius Medical Care (FMS) at 7.84% and Solventum (SOLV) at 3.19% land near their industries’ usual ROE ranges, so capital efficiency looks broadly in line with peers on both sides.

Both Fresenius Medical Care (FMS) at 4.22% and Solventum (SOLV) at 1.91% keep about the typical share of revenue as profit for their industries — neither bottom line stands out from peers.

Both Fresenius Medical Care (FMS) at 9.63% and Solventum (SOLV) at 6.82% run core operations about as efficiently as their industries’ norm — neither stands out on operating profitability.

Profitability Metrics

Growth

Both Fresenius Medical Care (FMS) at 1.51% and Solventum (SOLV) at 0.86% post bottom-quartile revenue growth versus peers, pointing to weaker demand or pricing momentum than typical rivals.

Both companies show strong earnings momentum, but Solventum (SOLV) at 221.74% is the standout with EPS growth above its industry range; Fresenius Medical Care (FMS) at 83.61% also sits in the top quartile.

Growth Metrics

Financial Strength

Both Fresenius Medical Care (FMS) at 0.99 and Solventum (SOLV) at 1.03 run current ratio in the tighter-liquidity quartile of industry peers, leaving thinner cushions against current liabilities than typical competitors.

Fresenius Medical Care (FMS) at 0.79 carries an industry-typical debt-to-equity mix, while Solventum (SOLV) at 1.10 uses more debt funding than most peers.

Financial Strength Metrics

Dividends

Solventum (SOLV) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Fresenius Medical Care (FMS) reports a yield of 6.30%, ranking against industry peers normally.

Solventum (SOLV) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Fresenius Medical Care (FMS) reports a payout of 50.14%, ranking against industry peers normally.

Dividend Metrics

Valuation

Fresenius Medical Care (FMS) at 13.53 sits in the cheaper P/E ratio quartile, while Solventum (SOLV) at 101.55 trades above its peer range — a wide earnings-valuation gap relative to industry peers.

Fresenius Medical Care (FMS) at 0.62 sits in the cheaper P/S ratio quartile while Solventum (SOLV) at 1.88 prices around its industry’s middle — FMS costs less per dollar of sales, though read it alongside growth and margins.

Fresenius Medical Care (FMS) at 0.85 sits in the lower P/B ratio quartile against book while Solventum (SOLV) at 3.20 is valued near its industry’s middle — FMS is cheaper on assets, though weigh it against ROE and asset quality.

Valuation Metrics